Dietary flavonoids: Intake, health effects and bioavailability

Food and Chemical Toxicology

Volumn 37, Issue 9-10, 1999, Pages 937-942

  Hollman, P C H ^a   Katan, M B ^b  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Antioxidants; Bioavailability; Dietary flavonoids; Epidemiology; Flavonol glycosides; LDL=low density lipoprotein; Quercetin

Indexed keywords

FLAVONOID; FLAVONOL; GLYCOSIDE; POLYPHENOL DERIVATIVE; QUERCETIN;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOAVAILABILITY; DIETARY INTAKE; FOOD COMPOSITION; FRUIT; HUMAN; VEGETABLE;

ANIMALIA;

EID: 0032819772     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(99)00079-4     Document Type: Short Survey

References (38)

1. Bergmark C., Wu R., de Faire U., Lefvert A. K., Swedenborg J. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arteriosclerosis, Thrombosis, and Vascular Biology. 15:1995;441-445.
2. Block G., Patterson B., Subar A. Fruit, vegetables, and cancer prevention: a review of epidemiological evidence. Nutrition and Cancer. 18:1992;1-29.
3. de Whalley C., Rankin S. M., Hoult J. R. S., Jessup W., Leake D. S. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochemical Pharmacology. 39:1990;1743-1750.
4. Frankel E. N., Kanner J., German J. B., Parks E., Kinsella J. E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 341:1993;454-457.
5. Goldbohm R. A., van den Brandt P. A., Hertog M. G. L., Brants H. A. M., van Poppel G. Flavonoid intake and risk of cancer: a prospective cohort study. American Journal of Epidemiology. 141:(Suppl.):1995;s61. (Abstract).
6. Griffiths L. A. (1982) Mammalian metabolism of flavonoids. In The Flavonoids: Advances in Research, ed. J. Harborne and T. Mabry, pp. 681-718. Chapman and Hall, London.
7. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet. 344:1994;721-724.
8. Hertog M. G. L., Feskens E. J. M., Hollman P. C. H., Katan M. B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 342:1993;1007-1011.
9. Hertog M. G. L., Feskens E. J. M., Hollman P. C. H., Katan M. B., Kromhout D. Dietary flavonoids and cancer risk in the Zutphen Elderly Study. Nutrition and Cancer. 22:1994;175-184.
10. Hertog M. G. L., Hollman P. C. H., Katan M. B. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. Journal of Agricultural and Food Chemistry. 40:1992;2379-2383.
11. Hertog M. G. L., Hollman P. C. H., Katan M. B., Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutrition and Cancer. 20:1993;21-29.
12. Hertog M. G. L., Hollman P. C. H., van de Putte B. Content of potentially anticarcinogenic flavonoids of tea infusions wines, and fruit juices. Journal of Agricultural and Food Chemistry. 41:1993;1242-1246.
13. Hertog M. G. L., Kromhout D., Aravanis C., Blackburn H., Buzina R., Fidanza F., Giampaoli S., Jansen A., Menotti A., Nedeljkovic S., Pekkarinen M., Simic B. S., Toshima H., Feskens E. J. M., Hollman P. C. H., Katan M. B. Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Archives of Internal Medicine. 155:1995;381-386.
14. Hertog M. G. L., Feskens E. J. M., Kromhout D. Antioxidant flavonols and coronary heart disease risk. Lancet. 349:1997;699.
15. Hertog M. G. L., Sweetnam P. M., Fehily A. M., Elwood P. C., Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. American Journal of Clinical Nutrition. 65:1997;1489-1494.
16. Hollman P. C. H., de Vries J. H. M., van Leeuwen S. D., Mengelers M. J. B., Katan M. B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. American Journal of Clinical Nutrition. 62:1995;1276-1282.
17. Hollman P. C. H. and Katan M. B. (1997a) Absorption, metabolism, and bioavailability of flavonoids. In Flavonoids in Health and Disease, ed. C. Rice-Evans and L. Packer, pp. 483-522. Marcel Dekker, New York.
18. Hollman P. C. H., van Trijp J. M. P., Buysman M. N. C. P., van der Gaag M. S., Mengelers M. J. B., de Vries J. H. M., Katan M. B. Relative bioavailability of the antioxidant quercetin from various foods in man. FEBS Letters. 418:1997;152-156.
19. Kandaswami C., Middleton E. Jr. Free radical scavenging and antioxidant activity of plant flavonoids. Advances in Experimental Medicine and Biology. 366:1994;351-376.
20. Keli S. O., Hertog M. G. L., Feskens E. J. M., Kromhout D. Flavonoids, antioxidant vitamins and risk of stroke. The Zutphen study. Archives of Internal Medicine. 156:1996;637-642.
21. Knekt P., Järvinen R., Reunanen A., Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. British Medical Journal. 312:1996;478-481.
22. Knekt P., Järvinen R., Seppänen R., Heliövaara M., Teppo L., Pukkala E., Aromaa A. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. American Journal of Epidemiology. 146:1997;223-230.
23. Kondo K., Matsumoto A., Kurata H., Tanahashi H., Koda H., Amachi T., Itakura H. Inhibition of oxidation of low-density lipoprotein with red wine. Lancet. 344:1994;1152-1152.
24. Kühnau J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Review of Nutrition and Dietetics. 24:1976;117-191.
25. Lanningham-Foster L., Chen C., Chance D. S., Loo G. Grape extract inhibits lipid peroxidation of human low density lipoprotein. Biological and Pharmaceutical Bulletin. 18:1995;1347-1351.
26. Mangiapane H. The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid. Biochemical Pharmacology. 43:1992;445-450.
27. st edn, pp. 619-652. Chapman & Hall, London.
28. Ness A. R., Powles J. W. Fruit and vegetables, and cardiovascular disease: a review. International Journal of Epidemiology. 26:1997;1-13.
29. Nègre-Salvayre A., Salvayre R. Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. Free Radical Biology and Medicine. 12:1992;101-106.
30. Rankin S. M., de Whalley C. V., Hoult J. R. S., Jessup W., Wilkins G. M., Collard J., Leake D. S. The modification of low density lipoprotein by the flavonoids myricetin and gossypetin. Biochemical Pharmacology. 45:1993;67-75.
31. Rice-Evans C. A., Miller N. J., Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biology and Medicine. 20:1996;933-956.
32. Rimm E. B., Katan M. B., Ascherio A., Stampfer M. J., Willett W. C. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Annals of Internal Medicine. 125:1996;384-389.
33. Salonen J. T., Ylä-Herttuala S., Yamamoto R., Butler S., Korpela H., Salonen R., Nyyssönen K., Palinski W., Witztum J. L. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 339:1992;883-887.
34. Shaikh M., Martini S., Quiney J. R., Baskerville P., La Ville A. E., Browse N. L., Duffield R., Turner P. R., Lewis B. Modified plasma-derived lipoproteins in human atherosclerotic plaques. Atherosclerosis. 69:1988;165-172.
35. Steinmetz K. A., Potter J. D. Vegetables, fruit and cancer. I. Epidemiology. Cancer Causes and Control. 2:1991;325-357.
36. Viana M., Barbas C., Bonet B., Bonet M. V., Castro M., Fraile M. V., Herrera E. In vitro effects of a flavonoid-rich extract on LDL oxidation. Atherosclerosis. 123:1996;83-91.
37. Wattenberg L. W. Inhibition of carcinogenesis by minor dietary constituents. Cancer Research. 52:(Suppl.):1992;2085S-2091S.
38. Wu T.-W., Fung K.-P., Wu J., Yang C.-C., Lo J., Weisel R. D. Morin hydrate inhibits azo-initiator induced oxidation of human low density lipoprotein. Life Sciences. 58:1996;17-22. PL.